Membrane localization and guanine nucleotide sensitivity of medullary I-1-imidazoline binding sites

被引:36
作者
Ernsberger, P
Shen, IH
机构
[1] CASE WESTERN RESERVE UNIV, DEPT PHARMACOL, SCH MED, CLEVELAND, OH 44106 USA
[2] CASE WESTERN RESERVE UNIV, DEPT NEUROSCI, SCH MED, CLEVELAND, OH 44106 USA
关键词
D O I
10.1016/S0197-0186(96)00033-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Imidazoline binding sites are labeled by [H-3]clonidine (I-1) or by [H-3]idazoxan (I-2). I-2-sites are mitochondrial. The subcellular localization of I-1-sites in brain is unknown. Crude membranes from bovine rostral ventrolateral medulla (RVLM) were further purified by discontinuous sucrose density gradient. Fractions were assayed for I-1-site density (B-max) with [I-125]p-iodoclonidine. Nonspecific binding was defined by 10 mu M BDF-6143, and alpha(2)-adrenergic binding was defined by 10 mu M epinephrine. The proportions of I-1 and alpha(2) in mitochondrial fractions were similar (28 +/- 3 and 24 +/- 4%, respectively), and both I-1 and alpha(2) showed the greatest enrichment within the membrane-enriched fraction (58 +/- 13 and 38 +/- 4%). The myelin fraction contained a higher proportion of alpha(2) than I-1 (38 +/- 4 and 15 +/- 2%), consistent with expression of alpha(2), but not I-1, by glia. The enrichment of I-1 and alpha(2) in cellular membranes and alpha(2) in myelin was confirmed by further purification of these fractions over a second discontinuous gradient. Following irreversible inactivation df alpha(2), the remaining I-1 sites in RVLM crude membranes were inhibited by Gpp(NH)p but not by ATP. We conclude that I-1-imidazoline sites are non-mitochondrial membrane proteins sensitive to guanine nucleotide and may be functional receptors. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 42 条
[1]   PERIKARYAL AND SYNAPTIC LOCALIZATION OF ALPHA(2A),-ADRENERGIC RECEPTOR-LIKE IMMUNOREACTIVITY [J].
AOKI, C ;
GO, CG ;
VENKATESAN, C ;
KUROSE, H .
BRAIN RESEARCH, 1994, 650 (02) :181-204
[2]  
BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232
[3]   LOCALIZATION OF CENTRAL CARDIOVASCULAR ACTION OF CLONIDINE [J].
BOUSQUET, P ;
GUERTZENSTEIN, PG .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 49 (04) :573-579
[4]   THE IMIDAZOLINE PREFERRING RECEPTOR - BINDING-STUDIES IN BOVINE, RAT AND HUMAN BRAIN-STEM [J].
BRICCA, G ;
DONTENWILL, M ;
MOLINES, A ;
FELDMAN, J ;
BELCOURT, A ;
BOUSQUET, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (01) :1-9
[5]   IMIDAZOLINE RECEPTORS, NONADRENERGIC IDAZOXAN BINDING-SITES AND ALPHA(2)-ADRENOCEPTORS IN THE HUMAN CENTRAL-NERVOUS-SYSTEM [J].
DEVOS, H ;
BRICCA, G ;
DEKEYSER, J ;
DEBACKER, JP ;
BOUSQUET, P ;
VAUQUELIN, G .
NEUROSCIENCE, 1994, 59 (03) :589-598
[6]  
ERNSBERGER P, 1990, J PHARMACOL EXP THER, V253, P408
[7]   ASTROCYTES CULTURED FROM SPECIFIC BRAIN-REGIONS DIFFER IN THEIR EXPRESSION OF ADRENERGIC BINDING-SITES [J].
ERNSBERGER, P ;
IACOVITTI, L ;
REIS, DJ .
BRAIN RESEARCH, 1990, 517 (1-2) :202-208
[8]  
Ernsberger P, 1995, Ann N Y Acad Sci, V763, P163, DOI 10.1111/j.1749-6632.1995.tb32402.x
[9]  
ERNSBERGER P, 1993, J PHARMACOL EXP THER, V264, P172
[10]  
Ernsberger P, 1995, Ann N Y Acad Sci, V763, P22, DOI 10.1111/j.1749-6632.1995.tb32388.x